These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini. Sarri E; Ramos B; Salido GM; Claro E Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors. Rodriguez M; Amblard M; Galas MC; Lignon MF; Aumelas A; Martinez J Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470 [TBL] [Abstract][Full Text] [Related]
25. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion. Villanueva ML; Martinez J; Bodanszky M; Collins SM; Jensen RT; Gardner JD Am J Physiol; 1982 Sep; 243(3):G214-7. PubMed ID: 6180646 [TBL] [Abstract][Full Text] [Related]
26. A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini. Matozaki T; Martinez J; Williams JA Am J Physiol; 1989 Oct; 257(4 Pt 1):G594-600. PubMed ID: 2478032 [TBL] [Abstract][Full Text] [Related]
27. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984 [TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin analogues with high affinity and selectivity for brain membrane receptors. Hruby VJ; Fang SA; Knapp R; Kazmierski W; Lui GK; Yamamura HI Int J Pept Protein Res; 1990 Jun; 35(6):566-73. PubMed ID: 2401597 [TBL] [Abstract][Full Text] [Related]
29. Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue. Sugg EE; Serra M; Shook JE; Yamamura HI; Burks TF; Korc M; Hruby VJ Int J Pept Protein Res; 1988 Jun; 31(6):514-9. PubMed ID: 2457563 [TBL] [Abstract][Full Text] [Related]
30. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179. Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190 [TBL] [Abstract][Full Text] [Related]
31. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor. McCort-Tranchepain I; Ficheux D; Durieux C; Roques BP Int J Pept Protein Res; 1992 Jan; 39(1):48-57. PubMed ID: 1378822 [TBL] [Abstract][Full Text] [Related]
32. Somatostatin 28 interacts with CCK receptor in brain and pancreas. Tahiri-Jouti N; Dufresne M; Viguerie N; Fourmy D; Estève JP; Rivier J; Moroder L; Susini C; Vaysse N Neuropeptides; 1991 Jun; 19(2):65-71. PubMed ID: 1719446 [TBL] [Abstract][Full Text] [Related]
33. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors. Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293 [TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate. Bodanszky M; Martinez J; Priestley GP; Gardner JD; Mutt V J Med Chem; 1978 Oct; 21(10):1030-5. PubMed ID: 722712 [TBL] [Abstract][Full Text] [Related]
36. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors. von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882 [TBL] [Abstract][Full Text] [Related]
37. Cyclic cholecystokinin analogues with high selectivity for central receptors. Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318 [TBL] [Abstract][Full Text] [Related]
38. Development of CCK-B antagonists. Horwell DC Neuropeptides; 1991 Jul; 19 Suppl():57-64. PubMed ID: 1881533 [TBL] [Abstract][Full Text] [Related]
39. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702. Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411 [TBL] [Abstract][Full Text] [Related]
40. Effect of estradiol on pancreatic amylase and cholecystokinin binding in ovariectomized guinea pigs. Guo YS; Singh P J Steroid Biochem; 1989 Sep; 33(3):459-64. PubMed ID: 2476588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]